| Secondary |
| Product Used For Unknown Indication |
23.8% |
| Epilepsy |
21.1% |
| Convulsion |
15.0% |
| Drug Exposure During Pregnancy |
6.1% |
| Drug Use For Unknown Indication |
5.4% |
| Grand Mal Convulsion |
4.1% |
| Complex Partial Seizures |
3.4% |
| Hiv Infection |
2.7% |
| Insomnia |
2.7% |
| Status Epilepticus |
2.7% |
| Suicide Attempt |
2.7% |
| Lennox-gastaut Syndrome |
2.0% |
| Agitation Neonatal |
1.4% |
| Maternal Exposure During Pregnancy |
1.4% |
| Myoclonic Epilepsy |
1.4% |
| Partial Seizures |
1.4% |
| Antidepressant Therapy |
0.7% |
| Gastritis |
0.7% |
| Hallucination |
0.7% |
| Neurosis |
0.7% |
|
| Toxicity To Various Agents |
25.0% |
| Cleft Lip And Palate |
11.1% |
| Mental Retardation |
8.3% |
| Overdose |
5.6% |
| Respiratory Tract Infection |
5.6% |
| Sepsis |
5.6% |
| Chest Pain |
2.8% |
| Drug Ineffective |
2.8% |
| Drug Interaction |
2.8% |
| Epilepsy |
2.8% |
| Hallucination, Auditory |
2.8% |
| Hyperammonaemia |
2.8% |
| Jaundice |
2.8% |
| Liver Injury |
2.8% |
| Maternal Drugs Affecting Foetus |
2.8% |
| Postictal State |
2.8% |
| Renal Failure Acute |
2.8% |
| Renal Impairment |
2.8% |
| Respiratory Depression |
2.8% |
| Screaming |
2.8% |
|
| Concomitant |
| Epilepsy |
28.7% |
| Product Used For Unknown Indication |
14.9% |
| Hiv Infection |
14.2% |
| Convulsion Prophylaxis |
6.9% |
| Convulsion |
6.6% |
| Drug Use For Unknown Indication |
5.2% |
| Rheumatoid Arthritis |
3.1% |
| Acquired Immunodeficiency Syndrome |
2.8% |
| Grand Mal Convulsion |
2.1% |
| Fluid Replacement |
1.7% |
| Intraocular Pressure Increased |
1.7% |
| Smoking Cessation Therapy |
1.7% |
| Cardiac Fibrillation |
1.4% |
| Gastritis |
1.4% |
| Glioblastoma |
1.4% |
| Infection Prophylaxis |
1.4% |
| Pyrexia |
1.4% |
| Sepsis Neonatal |
1.4% |
| Diarrhoea |
1.0% |
| Pain |
1.0% |
|
| Convulsion |
14.3% |
| Death |
8.9% |
| Pyrexia |
8.9% |
| Overdose |
5.4% |
| Prostate Cancer |
5.4% |
| Tremor |
5.4% |
| Vomiting |
5.4% |
| Weight Decreased |
5.4% |
| Asthenia |
3.6% |
| Drug Ineffective |
3.6% |
| Epilepsy |
3.6% |
| Pharmaceutical Product Complaint |
3.6% |
| Psychotic Disorder |
3.6% |
| Pulmonary Oedema |
3.6% |
| Spinal Disorder |
3.6% |
| Status Epilepticus |
3.6% |
| Tertiary Sequestrum |
3.6% |
| Toxicity To Various Agents |
3.6% |
| Urinary Incontinence |
3.6% |
| Abdominal Discomfort |
1.8% |
|
| Interacting |
| Epilepsy |
25.6% |
| Convulsion |
20.5% |
| Drug Use For Unknown Indication |
15.4% |
| Ex-smoker |
15.4% |
| Diabetes Mellitus |
10.3% |
| Product Used For Unknown Indication |
7.7% |
| Hypertension |
5.1% |
|
| Drug Interaction |
43.8% |
| Overdose |
25.0% |
| Suicidal Ideation |
12.5% |
| Vision Blurred |
12.5% |
| Liver Injury |
6.3% |
|
